导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -22.47% | 1020/1050 |
| 近一周 | -3.38% | 958/1104 |
| 近一月 | -3.70% | 633/1103 |
| 近一季 | -4.27% | 436/1092 |
| 近半年 | -21.62% | 1019/1070 |
| 近一年 | -27.66% | 971/1018 |
| 近两年 | -8.51% | 916/926 |
| 近三年 | -35.36% | 818/834 |
| 成立以来 | 79.71% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.09% 913/1070 |
-17.04% 1046/1101 |
- - |
- - |
| 2025 | 2.17% 914/1065 |
4.59% 437/1014 |
-2.69% 875/1038 |
4.62% 940/1050 |
-4.05% 670/1065 |
| 2024 | -7.86% 742/1011 |
-1.32% 389/960 |
-7.65% 772/983 |
13.92% 308/991 |
-11.24% 933/1011 |
| 2023 | -16.76% 593/952 |
5.13% 317/880 |
-13.11% 831/895 |
1.03% 57/915 |
-9.80% 849/952 |
| 2022 | -13.19% 137/867 |
-17.61% 397/773 |
18.35% 40/806 |
-12.56% 431/845 |
1.83% 331/867 |
| 2021 | - 349/740 |
-2.73% 254/580 |
9.88% 359/659 |
-10.24% 515/704 |
4.24% 254/740 |
| 2020 | 73.28% 129/554 |
-0.95% 183/419 |
32.95% 91/466 |
6.32% 338/517 |
23.76% 83/554 |
| 2019 | 71.20% 35/410 |
32.09% 260/1149 |
14.40% 3/1231 |
5.76% 188/390 |
7.13% 269/410 |
| 2018 | -11.02% 10/349 |
- - |
- - |
- - |
-5.45% 65/1080 |
| 2017 | 1.29% 174/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 创金合信消费主题股票A VS. 东吴新产业精选股票A(580008) |